LOADING
Comparing Eli Lilly and Company (LLY) and Broadcom Inc (AVGO) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | LLY | AVGO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $837.4B | $1.49T |
| P/E Ratio | 40.8 | 61.3 |
| Forward P/E | 28.0 | 28.2 |
| PEG Ratio | 1.03 | 0.68 |
| EPS | $22.92 | $5.13 |
| Revenue Growth (YoY) | 42.6% | 29.5% |
| Profit Margin | 31.7% | 36.6% |
| Return on Equity | 101.2% | 33.4% |
| Dividend Yield | 0.63% | 0.79% |
| Beta | 0.43 | 1.25 |
| 52-Week High | $1,132.06 | $412.95 |
| 52-Week Low | $620.46 | $136.99 |
| Volume | -- | -- |
Broadcom Inc is the larger company by market capitalization. Eli Lilly and Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Broadcom Inc offers a higher dividend yield for income investors. Broadcom Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.